These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19747645)

  • 1. Pandemic influenza: a priority for the neurological community.
    Lancet Neurol; 2009 Oct; 8(10):869. PubMed ID: 19747645
    [No Abstract]   [Full Text] [Related]  

  • 2. Guillain-Barré syndrome and H1N1 influenza vaccine in UK children.
    Verity C; Stellitano L; Winstone AM; Andrews N; Stowe J; Miller E
    Lancet; 2011 Oct; 378(9802):1545-6. PubMed ID: 22035553
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.
    Wu J; Xu F; Lu L; Lu M; Miao L; Gao T; Ji W; Suo L; Liu D; Ma R; Yu R; Zhangzhu J; Liu W; Zeng Y; Li X; Zhang X; Pang X; Deng Y
    N Engl J Med; 2010 Dec; 363(25):2416-23. PubMed ID: 21158658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far].
    Press R; Andersen O
    Lakartidningen; 2010 Mar 10-16; 107(10):666-7. PubMed ID: 20402249
    [No Abstract]   [Full Text] [Related]  

  • 5. Pandemic vaccines and small excess of Guillain-Barre cases.
    BMJ; 2013 Mar; 346():f1714. PubMed ID: 23516147
    [No Abstract]   [Full Text] [Related]  

  • 6. Guillain-Barré syndrome following H1N1 immunization in a pediatric patient.
    Tremblay ME; Closon A; D'Anjou G; Bussières JF
    Ann Pharmacother; 2010; 44(7-8):1330-3. PubMed ID: 20484170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré syndrome associated with H1N1 vaccination.
    Marin LF; Abrahão A; Carvalho FA; Santos WA; Dallalba CC; Barcelos LB; Silva GS; Oliveira AS
    Arq Neuropsiquiatr; 2010 Dec; 68(6):974-5. PubMed ID: 21243265
    [No Abstract]   [Full Text] [Related]  

  • 8. [Safety and effectiveness of the influenza vaccine: new data, new challenges].
    Trilla A
    Med Clin (Barc); 2013 Jul; 141(2):67-9. PubMed ID: 23768850
    [No Abstract]   [Full Text] [Related]  

  • 9. Pandemic influenza. Europe reconsiders H1N1 flu shots for children.
    Enserink M
    Science; 2009 Nov; 326(5955):922. PubMed ID: 19965485
    [No Abstract]   [Full Text] [Related]  

  • 10. H1N1 vaccine safety monitoring: beyond background rates.
    Destefano F; Tokars J
    Lancet; 2010 Apr; 375(9721):1146-7. PubMed ID: 19880171
    [No Abstract]   [Full Text] [Related]  

  • 11. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses.
    Tokars JI; Lewis P; DeStefano F; Wise M; Viray M; Morgan O; Gargiullo P; Vellozzi C
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):546-52. PubMed ID: 22407672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What we know about influenza vaccine and Guillain-Barré syndrome.
    Enos L
    Oreg Nurse; 2009 Nov; ():5. PubMed ID: 19998739
    [No Abstract]   [Full Text] [Related]  

  • 13. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses.
    Grimaldi-Bensouda L; Alpérovitch A; Besson G; Vial C; Cuisset JM; Papeix C; Lyon-Caen O; Benichou J; Rossignol M;
    Am J Epidemiol; 2011 Aug; 174(3):326-35. PubMed ID: 21652600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome in children aged <15 years in Latin America and the Caribbean: baseline rates in the context of the influenza A (H1N1) pandemic.
    Landaverde JM; Danovaro-Holliday MC; Trumbo SP; Pacis-Tirso CL; Ruiz-Matus C
    J Infect Dis; 2010 Mar; 201(5):746-50. PubMed ID: 20102270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of adjuvanted pandemic influenza A (H1N1) 2009 vaccines.
    DeStefano F; Vellozzi C; Schonberger LB; Chen RT
    BMJ; 2011 Jul; 343():d4159. PubMed ID: 21750073
    [No Abstract]   [Full Text] [Related]  

  • 16. Relapse of nephrotic syndrome following the use of 2009 pandemic influenza A (H1N1) vaccine.
    Fernandes P; Jorge S; Lopes JA
    Am J Kidney Dis; 2010 Jul; 56(1):185-6. PubMed ID: 20620684
    [No Abstract]   [Full Text] [Related]  

  • 17. H1N1 vaccine for prevention of pandemic influenza.
    Med Lett Drugs Ther; 2009 Oct; 51(1322):77-8. PubMed ID: 19798010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010.
    Polakowski LL; Sandhu SK; Martin DB; Ball R; Macurdy TE; Franks RL; Gibbs JM; Kropp GF; Avagyan A; Kelman JA; Worrall CM; Sun G; Kliman RE; Burwen DR
    Am J Epidemiol; 2013 Sep; 178(6):962-73. PubMed ID: 23652165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus.
    Lei T; Siu KL; Kok KH; Chan KH; Chan EY; Hung IF; To KK; Li PC; Zhou J; Zheng BJ; Yuen KY; Wang M; Jin DY
    Vaccine; 2012 Mar; 30(16):2605-10. PubMed ID: 22342549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pandemic (H1N1) 2009 influenza.
    Polkinghorne B; Ward K; Totaro R
    N S W Public Health Bull; 2010; 21(1-2):41-2. PubMed ID: 21367344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.